Discovery and Evaluation of Entry Inhibitors for SARS-CoV-2 and Its Emerging Variants

The outbreak of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is responsible for the coronavirus disease 19 (COVID-19) pandemic. Despite unprecedented research and developmental efforts, SARS-CoV-2-specific antivirals are still unavailable for the treatment of COVID-19. In most instan...

Descripción completa

Detalles Bibliográficos
Autores principales: Acharya, Arpan, Pandey, Kabita, Thurman, Michellie, Klug, Elizabeth, Trivedi, Jay, Sharma, Kalicharan, Lorson, Christian L., Singh, Kamal, Byrareddy, Siddappa N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Microbiology 2021
Materias:
Vaccines and Antiviral Agents
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8610590/
https://www.ncbi.nlm.nih.gov/pubmed/34550770
http://dx.doi.org/10.1128/JVI.01437-21

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8610590/
https://www.ncbi.nlm.nih.gov/pubmed/34550770
http://dx.doi.org/10.1128/JVI.01437-21

Ejemplares similares